Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Top highlights include: which insurance companies cover the new Alzheimer's drug, advice on how to talk to someone who is hesitant to get the COVID-19 vaccine, employers requiring you to be vaccinated, FDA approval Alzheimer drug, MN COVID-19 numbers heading in the right direction, having "brain frog" and blaming the pandemic.

In this episode, William Morice II, M.D., Ph.D., explains his dual leadership role at Mayo Clinic and discusses how engaging in the business of a reference laboratory informs his work within academic medicine.

The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the acceleration of brain tumor research and discovery translates into an ever-changing testing environment.

Bobbi Pritt, M.D., discusses how Mayo Clinic Labs’ updated PCR assay for West Nile virus provides increased sensitivity to detect virus RNA in multiple sources, identifies two virus lineages, and confirms diagnosis.

Top highlights include: Overcoming pandemic procrastination and how senolytics reduce COVID-19 symptoms in preclinical studies.

Top highlights include: what pain relievers you should take after surgery, COVID fear vs hope, expansion on insurance coverage for Medicare-Medicaid, DASH diets may cause more harm than good with high blood pressure, Mayo Clinic offering new "National Cancer Survivor day" video bilingual series, and the new launch of a Mayo Clinic southern mobile unit.

In this episode of Lab Medicine Rounds, Rondell Graham, M.B.B.S., associate professor of Laboratory Medicine and Pathology at Mayo Clinic, discusses the value and challenges of frozen sections.

Last year, when Brian Netzel was redeployed from Mayo Clinic's Biochemical Genetics Lab to a lab testing for COVID-19, he put his skills to work wherever they were needed — alongside hundreds of other Mayo staff doing the same as they battled the pandemic together.

Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo Clinic’s urology and nephrology expertise.

This week’s research roundup features a study on therapeutic trials in adult FSGS and lessons learned for the road forward.